Pancreatic Cancer Research

ResearcherSamsung Medical CenterActive in the last 2 years

Hochang Chae

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1484-4314; OpenAlex author ID A5010300557, A5042983055. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2025: 6 papers · 2026: 2 papers

Papers 8

  1. Familial Pancreatic Cancer at a Tertiary Referral Center: Incidence and Clinical Characteristics in Korea. First author DOI 10.1002/jhbp.70142↗
  2. Multivisceral resection for pancreatic ductal adenocarcinoma with adjacent organ invasion: a propensity score-matched analysis. Co-author DOI 10.1016/j.gassur.2026.102412↗
  3. Synthetic data generation method improves risk prediction model for early tumor recurrence after surgery in patients with pancreatic cancer. Co-author DOI 10.1038/s41598-025-15800-4↗
  4. Implications of portal vein/superior mesenteric vein involvement in pancreatic cancer: A comprehensive correlation from preoperative radiological assessment to… First author DOI 10.1097/js9.0000000000002307↗
  5. The impact of distress at diagnosis in patients with pancreatic cancer undergoing pancreatectomy. Co-author DOI 10.1186/s12885-025-14365-9↗
  6. Prognostic Accuracy of ypTNM Stage in Patients with Pancreatic Cancer in the Era of Modern Neoadjuvant Therapy. First author DOI 10.1245/s10434-024-16792-7↗
  7. Impact of portal/superior mesenteric vein abutment angle on prognosis in pancreatic cancer: a single-center retrospective cohort study. Co-author DOI 10.4174/astr.2025.108.4.231↗
  8. Predicting prognosis and optimal timing for surgery using CA 19-9 in patients with pancreatic cancer who underwent FOLFIRINOX-based neoadjuvant therapy: a retr… Co-author DOI 10.4174/astr.2025.109.6.348↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. In Woong Han · 8 shared papers, 2025–2026 · strength 2.16
  2. Hongbeom Kim · 8 shared papers, 2025–2026 · strength 2.16
  3. Sang Hyun Shin · 8 shared papers, 2025–2026 · strength 2.16
  4. Jin Seok Heo · 7 shared papers, 2025–2026 · strength 1.83
  5. Hyeong Seok Kim · 7 shared papers, 2025–2026 · strength 1.83
  6. So Jeong Yoon · 5 shared papers, 2025 · strength 1.27
  7. Hye Jeong Jeong · 5 shared papers, 2025 · strength 1.23
  8. Ji Hye Min · 2 shared papers, 2025 · strength 0.47
  9. Eugene Park · 1 shared paper, 2026 · strength 0.33
  10. Song Eun Yoon · 1 shared paper, 2025 · strength 0.25
  11. Seung Hyup Hyun · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.